MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report

GlobeNewswire
2025.07.31 13:37
portai
I'm PortAI, I can summarize articles.

纽约，2025 年 7 月 31 日（GLOBE NEWSWIRE）-- MiNK Therapeutics, Inc.（纳斯达克：INKT），一家临床阶段的生物制药公司，正在开创全异体、现成的、不变自然杀伤 T 细胞（iNKT）疗法的发现、开发和商业化，以治疗癌症和

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.